Cargando…

The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis

Background: Estrogen replacement therapy (ERT) is a common treatment method for menopausal syndrome; however, its therapeutic value for the treatment of neurological diseases is still unclear. Epidemiological studies were performed, and the effect of postmenopausal ERT on treating neurodegenerative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Yu-jia, Li, Shu-ran, Li, Xiao-wan, Chen, Xi, Wei, Ze-xu, Liu, Qing-shan, Cheng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076111/ https://www.ncbi.nlm.nih.gov/pubmed/32210745 http://dx.doi.org/10.3389/fnins.2020.00157

Ejemplares similares

Vaginal Flora in Postmenopausal Women: The Effect of Estrogen Replacement
por: Ginkel, Paul D., et al.
Publicado: (1993)

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
por: Peterson, Andrew C., et al.
Publicado: (2018)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Mitigating Effect of Estrogen in Alzheimer’s Disease-Mimicking Cerebral Organoid
por: Kim, Jennifer Yejean, et al.
Publicado: (2022)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
por: Siani, Francesca, et al.
Publicado: (2017)

Deep Brain Stimulation: A Potential Treatment for Dementia in Alzheimer's Disease (AD) and Parkinson's Disease Dementia (PDD)
por: Lv, Qing, et al.
Publicado: (2018)

The Emerging Role of Circular RNAs in Alzheimer’s Disease and Parkinson’s Disease
por: Zhang, Meng, et al.
Publicado: (2021)

The Ocular Benefits of Estrogen Replacement Therapy: A Population-Based Study in Postmenopausal Korean Women
por: Na, Kyung-Sun, et al.
Publicado: (2014)

Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
por: Boukhris, Marouane, et al.
Publicado: (2014)

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging
por: Rodriguez, Manuel, et al.
Publicado: (2014)

The Role of Estrogen Therapy as a Protective Factor for Alzheimer’s Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature
por: Ali, Noor, et al.
Publicado: (2023)

Association of dyslipidaemia with Alzheimer’s disease in a cohort of postmenopausal women
por: Li, Ning, et al.
Publicado: (2020)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
por: Arbo, Bruno Dutra, et al.
Publicado: (2020)

Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis
por: Cui, Lei, et al.
Publicado: (2020)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

Estrogens and Neuropeptides in Postmenopausal Women: Un Update
por: Guida, M., et al.
Publicado: (2012)

Estrogen, brain structure, and cognition in postmenopausal women
por: Boyle, Christina P., et al.
Publicado: (2020)

Retinal Ganglion Cells and Circadian Rhythms in Alzheimer’s Disease, Parkinson’s Disease, and Beyond
por: La Morgia, Chiara, et al.
Publicado: (2017)

The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
por: Ramirez, Ana I., et al.
Publicado: (2017)

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease
por: Awuson-David, Betina, et al.
Publicado: (2023)

Differential Circulating Levels of Naturally Occurring Antibody to α-Synuclein in Parkinson’s Disease Dementia, Alzheimer’s Disease, and Vascular Dementia
por: Wang, Jian, et al.
Publicado: (2020)

Impairment in the Intention Formation and Execution Phases of Prospective Memory in Parkinson's Disease
por: Jia, Shu-Hong, et al.
Publicado: (2018)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson’s Disease: Implications for Rehabilitation
por: Ferrazzoli, Davide, et al.
Publicado: (2016)

Klotho and Postmenopausal Hormone Replacement Therapy in Women with Chronic Kidney Disease
por: Park, Yoo Jin, et al.
Publicado: (2018)

Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia
por: Scholefield, Melissa, et al.
Publicado: (2021)

1036 Estrogen Hormone Replacement Therapy May Lower Risk of Recurrent Urinary Tract Infections in Postmenopausal Women
por: Dickter, Jana, et al.
Publicado: (2014)

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
por: Chin-Chan, Miguel, et al.
Publicado: (2015)

Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
por: Reich, Niklas, et al.
Publicado: (2020)

Mechanical Implications of Estrogen Supplementation in Early Postmenopausal Women
por: Wehrli, Felix W, et al.
Publicado: (2010)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
por: Wang, Ze
Publicado: (2020)

Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls
por: Shalash, Ali, et al.
Publicado: (2017)

Fibrinogen in Alzheimer’s Disease, Parkinson’s Disease and Lewy Body Dementia: A Mendelian Randomization Study
por: Zhang, Hanyu, et al.
Publicado: (2022)

Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women
por: Morgan, Melinda L., et al.
Publicado: (2009)

Biotic/Abiotic Stress-Driven Alzheimer's Disease
por: Li, Chang-Qing, et al.
Publicado: (2016)

Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
por: Wang, Ke, et al.
Publicado: (2023)

Estrogen Deficiency Induces Mitochondrial Damage Prior to Emergence of Cognitive Deficits in a Postmenopausal Mouse Model
por: Zhao, Wei, et al.
Publicado: (2021)

Slowing of EEG Background Activity in Parkinson’s and Alzheimer’s Disease with Early Cognitive Dysfunction
por: Benz, Nina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_533i98ugcllr4rajqaf05pb0gd